These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 36813268

  • 1. Comparative Pharmacokinetics and Injection Site Histopathology in Nude Mice Treated with Long-acting Buprenorphine Formulations.
    Illario JA, Osborn KG, Garcia AV, Sepulveda YJ, Momper JD, Kiel JW, Kirihennedige AS, Sun SA, Richter PJ.
    J Am Assoc Lab Anim Sci; 2023 Mar 01; 62(2):147-152. PubMed ID: 36813268
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Extended-release Buprenorphine, an FDAindexed Analgesic, Attenuates Mechanical Hypersensitivity in Rats (Rattus norvegicus).
    Alamaw ED, Franco BD, Jampachaisri K, Huss MK, Pacharinsak C.
    J Am Assoc Lab Anim Sci; 2022 Jan 01; 61(1):81-88. PubMed ID: 34903316
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effectiveness of two extended-release buprenorphine formulations during postoperative period in neonatal rats.
    Zhang M, Alamaw E, Jampachaisri K, Huss M, Pacharinsak C.
    PLoS One; 2022 Jan 01; 17(10):e0276327. PubMed ID: 36251720
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Population Pharmacokinetics of a Monthly Buprenorphine Depot Injection for the Treatment of Opioid Use Disorder: A Combined Analysis of Phase II and Phase III Trials.
    Jones AK, Ngaimisi E, Gopalakrishnan M, Young MA, Laffont CM.
    Clin Pharmacokinet; 2021 Apr 01; 60(4):527-540. PubMed ID: 33135125
    [Abstract] [Full Text] [Related]

  • 9. Comparing Three Formulations of Buprenorphine in an Incisional Pain Model in Mice.
    Lopez-Echeverria G, Alamaw E, Gorman G, Jampachaisri K, Huss MK, Pacharinsak C.
    J Am Assoc Lab Anim Sci; 2023 Nov 11; 62(6):531-537. PubMed ID: 38030144
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Open-label, rapid initiation pilot study for extended-release buprenorphine subcutaneous injection.
    Hassman H, Strafford S, Shinde SN, Heath A, Boyett B, Dobbins RL.
    Am J Drug Alcohol Abuse; 2023 Jan 02; 49(1):43-52. PubMed ID: 36001871
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A pharmacokinetic study of extended-release buprenorphine in cynomolgus monkeys (Macaca fasicularis).
    Klein H, Levinson BL, Leary SL, Dobson G.
    J Med Primatol; 2023 Dec 02; 52(6):369-373. PubMed ID: 37432036
    [Abstract] [Full Text] [Related]

  • 17. Lack of Absorption of a Sustained-release Buprenorphine Formulation Administered Subcutaneously to Athymic Nude Rats.
    Page CD, Sarabia-Estrada R, Hoffman RJ, Lo CP, Gades NM.
    J Am Assoc Lab Anim Sci; 2019 Sep 01; 58(5):597-600. PubMed ID: 31362805
    [Abstract] [Full Text] [Related]

  • 18. Evaluation and comparison of pharmacokinetic profiles and safety of two extended-release buprenorphine formulations in common marmosets (Callithrix jacchus).
    Fabian NJ, Mannion AJ, Jamiel M, Anderson DJ, Rower JE, Reilly CA, Menegas W, Muthupalani S, Ta C, Fox JG, Kramer R, Haupt JL.
    Sci Rep; 2023 Jul 22; 13(1):11864. PubMed ID: 37481609
    [Abstract] [Full Text] [Related]

  • 19. Plasma concentrations of buprenorphine following a single subcutaneous administration of a sustained release formulation of buprenorphine in sheep.
    Zullian C, Lema P, Lavoie M, Dodelet-Devillers A, Beaudry F, Vachon P.
    Can J Vet Res; 2016 Jul 22; 80(3):250-3. PubMed ID: 27408341
    [Abstract] [Full Text] [Related]

  • 20. Predictors of availability of long-acting medication for opioid use disorder.
    Shover CL, Humphreys K.
    Drug Alcohol Depend; 2019 Nov 01; 204():107586. PubMed ID: 31593871
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.